Abstract
1 Department of Intensive Care, Hôpital Raymond Poincaré (APHP), Garches, France 2 Laboratory of Infection & Inflammation _ U1173, School of Medicine Simone Veil, University Versailles Saint Quentin _ University Paris Saclay, INSERM, Montigny-le-Bretonneux, France 3 FHU SEPSIS (Saclay and Paris Seine Nord Endeavour to PerSonalize Interventions for Sepsis), RHU RECORDS (Rapid rEcognition of CORticosteroiD resistant or sensitive Sepsis), Garches, France 4 Vaccine Research Institute, Créteil, France 5 Inserm U955, Equipe 16, Créteil, France 6 University Paris-Est Créteil, Créteil, France *See also p. 2131. All authors have received grants from Programme d’Investissements d’Avenir to identify signatures for resistance to corticosteroids in sepsis that may include glucocorticoid-induced leucine zipper (ANR-18-RHUS-0004). Dr. Annane’s institution received funding from the French Government, Programme d’Investissements d’Avenir (ANR-18-RHUS-0004). Dr. Godot has disclosed that she does not have any potential conflicts of interest.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
